| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 121,599 | 122,426 | 140,873 | 253,634 | | Cost of Revenue | 91,391 | 56,710 | 161,267 | 233,957 | | | Gross Profit | 30,208 | 65,716 | (20,394) | 19,677 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (55,611) | 116,023 | 18,857 | 14,035 | | Non Recurring | 81,063 |
-
|
-
|
-
| | Others | 2,897 | 2,965 | 2,719 | 2,749 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,859 | (53,272) | (41,970) | 2,893 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,859 | (53,272) | (41,970) | 2,893 | | Interest Expense | 567 | 1,051 | 243 | 611 | | Income Before Tax | 1,292 | (54,323) | (42,213) | 2,282 | | Income Tax Expense | 621 | (20,491) | (16,758) | 1,506 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 671 | (33,832) | (25,455) | 776 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 671 | (33,832) | (25,455) | 776 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $671 | ($33,832) | ($25,455) | $776 |
|
0.31% Nasdaq 
0.05%
Income Statement
